Purple Biotech CEO Gil Efron to step down
Source: SeekingAlpha
2026-03-13 08:31:04 ET
More on Purple Biotech
- Seeking Alpha’s Quant Rating on Purple Biotech
- Historical earnings data for Purple Biotech
- Financial information for Purple Biotech
Read the full article on Seeking Alpha
For further details see:
Purple Biotech CEO Gil Efron to step down
Purple Biotech Ltd ADR (Sponsored) Level 3
NASDAQ: PPBT
PPBT Trading
0.48% G/L:
$4.21 Last:
3,427 Volume:
$4.07 Open:
PPBT Latest News
March 25, 2026 08:00:00 am
Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
March 13, 2026 08:00:00 am
Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results
PPBT Stock Data
$1,562,570
2,425,222
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
IL
Rehovot
